Media, swabs and kit supply you can count on
At Thermo Fisher Scientific Microbiology, we have remained focused and flexible to ramp up production and deliver the EC-IVD approved and FDA-cleared products that you rely on. This is all to meet your testing demands during the coronavirus pandemic and beyond.
Our brand new, state-of-the-art facilities in both the US and UK have allowed us to upscale to 8 million viral collection and transport kits per week.
Our mission remains to make the world healthier, cleaner and safer.
Select your product mix by asking our experts:
Broad flexible product range
Innovation in Culture Media
8 million tubes manufactured per week
Quality you can rely on
An introduction to our core viral transport media product range
|MicroTest™ M4™||MicroTest™ M4RT™||MicroTest™ M5™||MicroTest™ M6™|
|Contains: gelatin, vancomycin, amphotericin B, and colistin for the transport of viruses, Chlamydiae, Ureaplasmas, and Mycoplasmas.||Contains: gelatin, gentamicin, and amphotericin B for the transport of viruses and Chlamydiae.||Contains: vancomycin, amphotericin B, and colistin and protein stabilizers for the transport of viruses, Chlamydiae, Ureaplasmas, and Mycoplasmas.||Contains: gelatin, vancomycin, amphotericin B, and colistin for the transport of viruses, Chlamydiae, Ureaplasmas, and Mycoplasmas.|
Keeping microbiology supply chains open during coronavirus
When healthcare systems are working at full capacity, they need the unwavering support of their supply chains. High demand for SARS-CoV-2 testing has seen many companies redeploy capacity and resources.
Our latest research looks at the consequences of supply shortages on routine healthcare, antimicrobial resistance, and the system’s ability to mount an effective pandemic response – as well as what we at Thermo Fisher Scientific are doing to maintain both supply of traditional testing and viral sample collection materials.